Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

Front Oncol. 2022 Apr 20:12:892408. doi: 10.3389/fonc.2022.892408. eCollection 2022.

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.783803.].

Keywords: EMT; PEMFs; TRPC1; breast cancer; chemotherapy; chorioallantoic membrane; doxorubicin; patient-derived xenograft.

Publication types

  • Published Erratum